Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

September 15, 2017 07:05 ET | Source: Myriad Genetics, Inc.

Myriad Genetics Announces Positive Data Supporting New riskScore™ Test at the 36th Annual Conference of the National Society of Genetic Counselors

SALT LAKE CITY, Sept. 15, 2017 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ:MYGN), a leader in molecular diagnostics and personalized medicine, today announced that two important studies will...
September 12, 2017 07:05 ET | Source: Myriad Genetics, Inc.

Myriad Genetics to Present Three Studies at the 2017 National Society of Genetic Counselors Annual Conference

SALT LAKE CITY, Sept. 12, 2017 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ:MYGN), a leader in molecular diagnostics and personalized medicine, today announced that it will present results from...
September 05, 2017 16:05 ET | Source: Myriad Genetics, Inc.

Myriad Launches riskScore™ Beginning the Next Epoch in Hereditary Cancer Testing

SALT LAKE CITY, Sept. 05, 2017 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ:MYGN), a leader in molecular diagnostics and personalized medicine, announced today that it has launched riskScore™,...
August 30, 2017 07:05 ET | Source: Myriad Genetics, Inc.

Myriad Genetics to Present at the 2017 Morgan Stanley Global Healthcare Conference

SALT LAKE CITY, Aug. 30, 2017 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ:MYGN), a leader in molecular diagnostics and personalized medicine, announced today that Mark C. Capone, president and...
August 29, 2017 16:05 ET | Source: Myriad Genetics, Inc.

Myriad Genetics to Present at the 2017 Wells Fargo Healthcare Conference

SALT LAKE CITY, Aug. 29, 2017 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ:MYGN), a leader in molecular diagnostics and personalized medicine, announced today that Mark C. Capone, president...
August 17, 2017 16:15 ET | Source: Myriad Genetics, Inc.

EndoPredict® Receives Positive Coverage Decisions From Medicare and Anthem

SALT LAKE CITY, Aug. 17, 2017 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ:MYGN), a leader in molecular diagnostics and personalized medicine, announced today that Palmetto GBA, the Medicare...
August 08, 2017 16:05 ET | Source: Myriad Genetics, Inc.

Myriad Genetics Reports Fiscal Fourth-Quarter 2017 and Fiscal Full-Year 2017 Financial Results

Total Revenues of $200.5 Million Up 8 PercentGAAP Diluted EPS was $0.19 and Adjusted EPS of $0.30Record Hereditary Cancer Demand and 86 Percent of Revenue Under Long-Term ContractCompany Issues Fiscal...
July 28, 2017 11:16 ET | Source: Myriad Genetics, Inc.

Myriad to Announce Fiscal Fourth-Quarter 2017 Financial Results on August 8, 2017

SALT LAKE CITY, July 28, 2017 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ:MYGN) today announced that it will hold its fiscal fourth-quarter 2017 sales and earnings conference call with...
June 19, 2017 07:05 ET | Source: Myriad Genetics, Inc.

Virginia C. Drosos, President of Assurex Health, Receives the EY Entrepreneur of the Year 2017 Award in Ohio Valley Region

SALT LAKE CITY, June 19, 2017 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ:MYGN), a leader in molecular diagnostics and personalized medicine, today announced that Virginia (“Gina”) C. Drosos,...
June 15, 2017 07:05 ET | Source: Myriad Genetics, Inc.

Crescendo Bioscience Announces Results from a Meta-Analysis of Studies with Vectra® DA at the 2017 Annual European Congress of Rheumatology

SALT LAKE CITY, June 15, 2017 (GLOBE NEWSWIRE) -- Crescendo Bioscience, a wholly-owned subsidiary of Myriad Genetics, Inc. (NASDAQ:MYGN), today announced that new data from a meta-analysis of...